✦ LIBER ✦

Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans

✍ Scribed by M. Katashima; K. Yamamoto; Y. Tokuma; T. Hata; Y. Sawada; T. Iga

Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 701 KB
Volume: 23
Category: Article
ISSN: 0378-7966
DOI: 10.1007/bf03189822

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simultaneous estimation of four proton p

Simultaneous estimation of four proton pump inhibitors—lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study

✍ D. Vijaya Bharathi; Kishore Kumar Hotha; B. Jagadeesh; Pankaj K. Chatki; K. Thri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

Differential stereoselective pharmacokin

Differential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole—a preliminary study

✍ M. Tanaka; H. Yamazaki; H. Hakusui; N. Nakamichi; H. Sekino 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Pantoprazole (PAN) is a proton pump inhibitor that is administered as a racemic mixture. The pharmacokinetics of PAN enantiomers were investigated in extensive metabolizers (EMs) and apparent poor metabolizers (PMs) of PAN who received a single 40, 60, or 80 mg oral dose of racemic PAN as enteric-co